Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention

Archives of Internal Medicine

Volumn 165, Issue 13, 2005, Pages 1547-1551

  Verhamme, Katia M C ^a   Dieleman, Jeanne P ^a   Van Wijk, Marc A M ^a   Van Der Lei, Johan ^a   Bosch, Joseph L H R ^a,b   Stricker, Bruno H C ^a   Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Utrecht Medical Center   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; URINE RETENTION;

ACUTE DISEASE; AGE DISTRIBUTION; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUSCLE CONTRACTION; NETHERLANDS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER; URINARY RETENTION;

EID: 23044451172     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.13.1547     Document Type: Article

References (18)

1. Dawson C, Whitfield H. ABC of urology: urological emergencies in general practice. BMJ. 1996;312:838-840.
2. Emberton M, Anson K. Acute urinary retention in men: an age old problem. BMJ. 1999;318:921-925.
3. Thomas K, Chow K, Kirby RS. Acute urinary retention: a review of the aetiology and management. Prostate Cancer Prostatic Dis. 2004;7:32-37.
4. Park JM, Schnermann JB, Briggs JP. Cyclooxygenase-2: a key regulator of bladder prostaglandin formation. Adv Exp Med Biol. 1999;462:171-181.
5. Wheeler MA, Yoon JH, Olsson LE, Weiss RM. Cyclooxygenase-2 protein and prostaglandin E2 production are up-regulated in a rat bladder inflammation model. Eur J Pharmacol. 2001;417:239-248.
6. Zhang Y, Schneider A, Rao E, et al. Genomic structure and genitourinary expression of mouse cytosolic prostaglandin E2 synthase gene. Biochim Biophys Acta. 2003;1634:15-23.
7. Park JM, Houck CS, Sethna NF, et al. Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation. Anesth Analg. 2000;91:11-15.
8. Ouslander JG. Management of overactive bladder. N Engl J Med. 2004;350:786-799.
9. Gruenenfelder J, McGuire EJ, Faerber GJ. Acute urinary retention associated with the use of cyclooxygenase-2 inhibitors. J Urol. 2002;168:1106.
10. Schrijver AJP. Health and Health Care in the Netherlands: A Critical Self-Assessment of Dutch Experts in Medical and Health Sciences. Utrecht, the Netherlands: De Tijdstroom; 1997.
11. Lamberts H, Wood M, Hofmans-Okkes IM. International Primary Care Classifications: the effect of fifteen years of evolution. Fam Pract. 1992;9:330-339.
12. Van der Lei J, Duisterhout JS, Westerhof HP, et al. The introduction of computer-based patient records in the Netherlands. Ann Intern Med. 1993;119:1036-1041.
13. World Health Organization (WHO). Anatomical Therapeutic Chemical Index With Defined Daily Doses. Oslo, Norway: WHO Collaborating Center for Drug Statistics Methodology; 2002.
14. Vlug AE, van der Lei J, Mosseveld BM, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med. 1999;38:339-344.
15. Hennekens CH, Buring JE. Epidemiology in Medicine. Boston, Mass: Little Brown & Co; 1987:87-98.
16. Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epidemiological terminology. Am J Epidemiol. 1999;149:981-983.
17. Horwitz RI, Feinstein AR. The problem of "protopathic bias" in case-control studies. Am J Med. 1980;68:255-258.
18. Choong S, Emberton M. Acute urinary retention. BJU Int. 2000;85:186-201.